PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy

Tumor growth can be further suppressed by pericyte inhibitor; however, metastases are potentially enhanced. More in-depth studies are warranted to confirm the potential benefits and risks of anti-pericyte therapy.